03:10 PM EDT, 08/09/2024 (MT Newswires) -- Kiora Pharmaceuticals ( KPRX ) shares were up more than 3% in recent Friday trading after the company narrowed its Q2 losses.

Kiora reported a Q2 diluted net loss of $0.53 per share, compared with a loss of $7.15 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.86.

The clinical-stage biotechnology company reported revenue for the quarter ended June 30 of $20,000.

Kiora said it could fund its operations through 2027.

Price: 3.38, Change: +0.12, Percent Change: +3.68